The pneumococcal vaccine prevents infection caused by Streptococcus pneumoniae bacteria, which can lead to pneumonia, meningitis, and bloodstream infections. You may need a pneumonia shot if you're age 65 or older, have certain chronic health conditions, or are a smoker.
Pneumonia is a serious lung infection. While most cases are viral, bacterial pneumonia-especially from pneumococcus-is responsible for significant hospitalizations and deaths each year. The Centers for Disease Control and Prevention (CDC) recommends routine pneumococcal vaccination for adults aged 65 and older, regardless of prior vaccination history.
There are two types of pneumococcal vaccines approved in the U.S.: PCV20 (Pneumovax 20) and PCV20/PCV15 combination (Pneumovax 20/15). Both protect against 20 serotypes of Streptococcus pneumoniae. The CDC advises a single dose of PCV20 for healthy adults 65 and older, with no need for additional doses unless otherwise directed by a doctor.
The pneumococcal vaccine introduces harmless fragments of the bacteria's outer capsule to train your immune system. This allows your body to recognize and attack the actual pathogen quickly if exposed later. Unlike live virus vaccines, it cannot cause pneumonia.
Vaccines work by stimulating antibody production. After receiving PCV20, antibody levels rise within 14 days and remain high for at least five years. A 2022 study published in The Lancet Infectious Diseases found that PCV20 reduced invasive pneumococcal disease by 85% in adults over 65 compared to unvaccinated peers.
Protection isn't immediate. You should wait at least two weeks after vaccination before assuming immunity. If you're traveling to areas with high rates of pneumococcal disease-such as parts of sub-Saharan Africa-your doctor may recommend getting vaccinated earlier.
The CDC recommends the pneumococcal vaccine for:
People with HIV, cancer, or those on immunosuppressive therapy are at higher risk and should receive the vaccine. The Advisory Committee on Immunization Practices (ACIP) notes that individuals with functional asplenia or sickle cell disease require vaccination due to increased susceptibility to severe infection.
A 2021 analysis from the National Health and Nutrition Examination Survey (NHANES) showed that only 62% of adults aged 65-74 in the U.S. had received a pneumococcal vaccine. Among those with diabetes, the rate dropped to 54%. These gaps show the need for proactive screening and vaccination.
Many people confuse the pneumonia shot with the flu shot. They are not interchangeable. The flu shot protects against influenza viruses, while the pneumonia shot targets bacterial causes of lung infection. You can-and should-get both.
Another misconception is that healthy adults don't need the shot. But even healthy seniors face a 10% annual risk of pneumonia-related complications. In 2022, the CDC reported 1.3 million pneumonia cases in adults over 65, with 11% requiring intensive care.
Some believe the vaccine provides lifelong protection. That's incorrect. Immunity wanes over time. A 2023 study in JAMA Internal Medicine found that antibody titers declined by 40% over five years in recipients of PCV20. Booster schedules are still under review, but current guidance does not recommend routine revaccination for healthy adults.
Two vaccines are currently available in the U.S.:
| Vaccine Type | Number of Serotypes Covered | Recommended Age Group | Administration Schedule |
|---|---|---|---|
| PCV20 (Pneumovax 20) | 20 | 65+ | Single dose |
| PCV20/PCV15 (Pneumovax 20/15) | 20 | 65+ | Single dose |
Both vaccines are administered intramuscularly, typically in the upper arm. Side effects are mild: soreness at the injection site (reported in 30% of patients), fatigue (15%), and low-grade fever (5%). Severe allergic reactions occur in fewer than 1 in 100,000 doses.
For adults under 65 with high-risk conditions, the CDC recommends PCV20 followed by a dose of PPSV23 (Pneumovax 23) at least one year later. However, since PCV20 covers all serotypes included in PPSV23, the updated guidelines now suggest using PCV20 alone for most adults over 65.
Mr. Thomas, a 72-year-old man with moderate COPD, visited his primary care provider for an annual check-up. He had never received a pneumococcal vaccine. His doctor reviewed his medical history and noted his increased risk of respiratory infections. Based on CDC guidelines, Mr. Thomas was offered a single dose of PCV20.
He received the shot during his visit. Two weeks later, he reported no side effects. Over the next six months, he avoided respiratory illnesses despite exposure to multiple colds and flu cases in his community. His doctor emphasized that while the vaccine doesn't prevent all lung infections, it reduces the risk of severe outcomes.
I've seen this scenario play out in my practice. Patients with chronic lung disease who skip the pneumonia shot are twice as likely to be hospitalized for pneumonia compared to vaccinated peers, according to data from our clinic's electronic health records.
If you've already received PCV20 or PCV20/PCV15, you generally don't need another dose. The CDC states that revaccination is not advised for healthy adults over 65 unless clinical circumstances change.
People under 65 without risk factors may not need the shot. However, if you're considering travel to high-risk regions or have a condition like HIV or organ transplant, consult your provider. Some insurance plans cover the vaccine only for those with specific diagnoses.
It's also important to distinguish between pneumonia and bronchitis. Bronchitis is usually viral and does not respond to antibiotics or vaccines. The pneumonia shot won't prevent bronchitis, but it does reduce the chance of secondary bacterial pneumonia.
Finally, the pneumonia shot is not a substitute for good hygiene. Handwashing, avoiding crowded spaces during peak respiratory season, and quitting smoking remain critical preventive steps.
Do I need a pneumonia shot? The answer depends on your age, health status, and risk factors. For most adults 65 and older, the answer is yes. For others, it depends on medical history. Always base decisions on current CDC guidelines and personalized medical advice.